MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 136 filers reported holding MACROGENICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $64,000 | +14.3% | 18,345 | 0.0% | 0.02% | +33.3% |
| Q2 2022 | $56,000 | -65.4% | 18,345 | 0.0% | 0.01% | -62.5% |
| Q1 2022 | $162,000 | -47.7% | 18,345 | 0.0% | 0.03% | -40.7% |
| Q4 2021 | $310,000 | -17.8% | 18,345 | 0.0% | 0.05% | -21.7% |
| Q3 2021 | $377,000 | -27.8% | 18,345 | 0.0% | 0.07% | -31.7% |
| Q2 2021 | $522,000 | -20.8% | 18,345 | -12.3% | 0.10% | -27.3% |
| Q1 2021 | $659,000 | +54.7% | 20,915 | 0.0% | 0.14% | +43.3% |
| Q4 2020 | $426,000 | -21.1% | 20,915 | 0.0% | 0.10% | -34.0% |
| Q3 2020 | $540,000 | +332.0% | 20,915 | -12.3% | 0.15% | +20.5% |
| Q1 2020 | $125,000 | – | 23,845 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $19,316,000 | 17.74% |
| Rhenman & Partners Asset Management AB | 967,186 | $17,390,000 | 2.03% |
| BB BIOTECH AG | 3,400,000 | $61,132,000 | 1.54% |
| Hood River Capital Management LLC | 1,443,196 | $25,949,000 | 1.31% |
| Sofinnova Investments, Inc. | 523,756 | $9,418,000 | 0.91% |
| Prosight Management, LP | 107,560 | $1,934,000 | 0.85% |
| 683 Capital Management, LLC | 484,970 | $8,720,000 | 0.79% |
| Bellevue Group AG | 790,305 | $14,210,000 | 0.78% |
| Opus Point Partners Management, LLC | 30,075 | $541,000 | 0.73% |
| Rubric Capital Management LP | 282,200 | $5,074,000 | 0.47% |